IFNL1 and influenza: Notably, coinfection of PCV2 and PRV also promotes the expression of IFN-λ1, which is consistent with previous reports that type III IFN can be used to inhibit influenza and coronavirus infections [45,46], suggesting that type III IFN is a promising antiviral agent against PCV2 and/or PRV infections.